Stryker Corporation
$334.05
▲
2.06%
2026-04-22 10:12:13
www.stryker.com
NYQ: SYK
Explore Stryker Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$127.84 B
Current Price
$334.05
52W High / Low
$404.87 / $319.32
Stock P/E
39.78
Book Value
$58.61
Dividend Yield
1.04%
ROCE
12.63%
ROE
15.08%
Face Value
—
EPS
$8.4
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
56,000
Beta
0.93
Debt / Equity
72.97
Current Ratio
1.89
Quick Ratio
1.21
Forward P/E
20.27
Price / Sales
5.17
Enterprise Value
$142.05 B
EV / EBITDA
20.44
EV / Revenue
5.66
Rating
Buy
Target Price
$420.62
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 2. | Inogen, Inc. | $6.95 | — | $185.18 M | — | -12.85% | -12.43% | $9.13 / $5.34 | $7.06 |
| 3. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 4. | Standard BioTools Inc. | $0.97 | — | $361.83 M | — | -20.31% | -13.13% | $1.72 / $0.87 | $1.23 |
| 5. | Nortech Systems Incorporated | $14.29 | — | $40.36 M | — | 2.95% | -0.73% | $14.61 / $6.5 | $12.31 |
| 6. | Electromed, Inc. | $25.4 | 23.98 | $215.65 M | — | 22.29% | 20.2% | $30.73 / $17.73 | $5.49 |
| 7. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 7.17 B | 6.06 B | 6.02 B | 5.87 B | 6.44 B |
| Operating Profit | 1.81 B | 1.21 B | 1.17 B | 872 M | 1.56 B |
| Net Profit | 849 M | 859 M | 884 M | 654 M | 546 M |
| EPS in Rs | 2.22 | 2.24 | 2.31 | 1.71 | 1.43 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 25.12 B | 22.59 B | 20.5 B | 18.45 B |
| Operating Profit | 5.06 B | 4.67 B | 3.92 B | 3.11 B |
| Net Profit | 3.25 B | 2.99 B | 3.17 B | 2.36 B |
| EPS in Rs | 8.48 | 7.81 | 8.26 | 6.16 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 47.84 B | 42.97 B | 39.91 B | 36.88 B |
| Total Liabilities | 25.42 B | 22.34 B | 21.32 B | 20.27 B |
| Equity | 22.42 B | 20.63 B | 18.59 B | 16.62 B |
| Current Assets | 14.76 B | 14.85 B | 12.52 B | 10.28 B |
| Current Liabilities | 7.79 B | 7.62 B | 7.92 B | 6.3 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 5.04 B | 4.24 B | 3.71 B | 2.62 B |
| Investing CF | -4.87 B | -3 B | -962 M | -2.92 B |
| Financing CF | 113 M | -525 M | -1.59 B | -749 M |
| Free CF | 4.28 B | 3.49 B | 3.14 B | 2.04 B |
| Capex | -761 M | -755 M | -575 M | -588 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 10.23% | 11.11% | — | — |
| Earnings Growth % | -5.43% | 34.22% | — | — |
| Profit Margin % | 13.25% | 15.44% | 12.78% | — |
| Operating Margin % | 20.65% | 19.14% | 16.86% | — |
| Gross Margin % | 63.91% | 63.7% | 62.76% | — |
| EBITDA Margin % | 21.91% | 24.7% | 22.27% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-31 | $0.88 |
| 2025-12-31 | $0.88 |
| 2025-09-30 | $0.84 |
| 2025-06-30 | $0.84 |
| 2025-03-31 | $0.84 |
Stock Splits
No stock split history available.